Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Myogen
company
About
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $14M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1996
- Number Of Employee
- 51 - 100
- Operating Status
- Close
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$54M
Myogen has raised a total of
$54M
in funding over 2 rounds. Their latest funding was raised on
Aug 29, 2003 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 29, 2003 | Series D | $40M | 1 | — | — | Detail |
| Jan 3, 2002 | Series D | $14M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Myogen is funded by 2 investors.
Perseus-Soros Biopharmaceutical Fund
and Tenex Medical Investors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Perseus-Soros Biopharmaceutical Fund
|
— | Series D |
Tenex Medical Investors
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
